SummaryRecent studies showing the therapeutic effect of young blood on agingâassociated deterioration of organs point to young blood as the solution for clinical problems related to old age. Given that defective autophagy has been implicated in aging and agingâassociated organ injuries, this study was designed to determine the effect of young blood on agingâinduced alterations in hepatic function and underlying mechanisms, with a focus on autophagy. Aged rats (22Â months) were treated with pooled plasma (1Â ml, intravenously) collected from young (3Â months) or aged rats three times per week for 4Â weeks, and 3âmethyladenine or wortmannin was used to inhibit young bloodâinduced autophagy. Aging was associated with elevated levels of alanine transaminase and aspartate aminotransferase, lipofuscin accumulation, steatosis, fibrosis, and defective liver regeneration after partial hepatectomy, which were significantly attenuated by young plasma injections. Young plasma could also restore agingâimpaired autophagy activity. Inhibition of the young plasmaârestored autophagic activity abrogated the beneficial effect of young plasma against hepatic injury with aging. In vitro, young serum could protect old hepatocytes from senescence, and the antisenescence effect of young serum was abrogated by 3âmethyladenine, wortmannin, or small interfering RNA to autophagyârelated protein 7. Collectively, our data indicate that young plasma could ameliorate ageâdependent alterations in hepatic function partially via the restoration of autophagy.